For example, combining chemotherapeutic agents like lomustine or etoposide with GSK-J4, a KDM2B inhibitor that decreases GBM cell viability and sensitizes GBM cells to chemotherapy, is a promising GBM treatment [99]. The gene discussed is KDM2B; the disease is glioblastoma.